Search Results for "Glyset"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Glyset. Results 1 to 4 of 4 total matches.
See also: miglitol

Miglitol for Type 2 Diabetes Mellitus

   
The Medical Letter on Drugs and Therapeutics • May 21, 1999  (Issue 1053)
FOR ONLINE USERS MIGLITOL FOR TYPE 2 DIABETES MELLITUS Miglitol (Glyset − Pharmacia & Upjohn), an oral ...
Miglitol, an oral alpha-glucosidase inhibitor similar to acarbase, is now available for treatment of type 2 diabetes.
Med Lett Drugs Ther. 1999 May 21;41(1053):49-50 |  Show IntroductionHide Introduction

Nateglinide For Type 2 Diabetes

   
The Medical Letter on Drugs and Therapeutics • Apr 02, 2001  (Issue 1101)
Inhibitors Acarbose − Precose (Bayer) 50 to 100 mg t.i.d. with meals $ 48.60 Miglitol − Glyset (Pharmacia ...
Nateglinide (Starlix), a new meglitinide oral glucose-lowering agent, has been approved by the FDA.
Med Lett Drugs Ther. 2001 Apr 2;43(1101):29-30 |  Show IntroductionHide Introduction

Rosiglitazone for Type 2 Diabetes Mellitus

   
The Medical Letter on Drugs and Therapeutics • Aug 13, 1999  (Issue 1059)
Acarbose − Precose (Bayer) 50 to 100 mg tid with meals 46.54 Miglitol − Glyset (Pharmacia & Upjohn) 50 ...
Rosiglitazone, the second thiazolidinedione derivative to be marketed in the USA for treatment of type 2 diabetes, has been approved by the FDA for use either alone or combined with meformin.
Med Lett Drugs Ther. 1999 Aug 13;41(1059):71-3 |  Show IntroductionHide Introduction

Pramlintide (Symlin) for Diabetes

   
The Medical Letter on Drugs and Therapeutics • May 23, 2005  (Issue 1209)
) or miglitol (Glyset). The package insert states that mixing pramlintide in the same syringe with insulin ...
Pramlintide acetate (Symlin - Amylin Pharmaceuticals), a synthetic analog of human amylin, has been approved by the FDA as adjunctive treatment for patients with type 1 or type 2 diabetes who inject insulin at mealtimes and have failed to achieve glucose control. Pramlintide is injected subcutaneously before meals.
Med Lett Drugs Ther. 2005 May 23;47(1209):43-4 |  Show IntroductionHide Introduction